Roberts, Glore & Co’s Organon & Co OGN Stock Holding History

Roberts, Glore & Co’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,826	Closed	-$206K	–	210
2024 Q4	$206K	Hold	13,826	–	–	0.06%	199
2024 Q3	$264K	Sell	13,826 -400	-3%	-$8.29K	0.08%	182
2024 Q2	$294K	Hold	14,226	–	–	0.09%	167
2024 Q1	$267K	Sell	14,226 -3,858	-21%	-$66.2K	0.08%	172
2023 Q4	$261K	Sell	18,084 -7,136	-28%	-$97.1K	0.08%	177
2023 Q3	$438K	Sell	25,220 -8,346	-25%	-$174K	0.14%	122
2023 Q2	$699K	Buy	33,566 +3,203	+11%	+$69.6K	0.22%	96
2023 Q1	$714K	Buy	30,363 +468	+2%	+$12.6K	0.24%	90
2022 Q4	$835K	Sell	29,895 -673	-2%	-$17.2K	0.29%	83
2022 Q3	$715K	Buy	30,568 +2,150	+8%	+$64.9K	0.26%	89
2022 Q2	$959K	Sell	28,418 -700	-2%	-$24.5K	0.32%	75
2022 Q1	$1.02M	Buy	29,118 +327	+1%	+$11.2K	0.29%	79
2021 Q4	$877K	Buy	+28,791	New	+$938K	0.23%	90

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Roberts, Glore & Co's OGN Position: Q1 2025 in Review

Roberts, Glore & Co sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 13,826 shares — an estimated $206K sold.

Roberts, Glore & Co first reported a position in OGN in Q4 2021 and held it in 13 quarters. The position peaked at $1.02M in Q1 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

Roberts, Glore & Co reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
Roberts, Glore & Co sold 13,826 Organon & Co shares in Q1 2025, an estimated $206K.
Roberts, Glore & Co first reported a position in Organon & Co in Q4 2021 and held it in 13 quarters.
Roberts, Glore & Co's Organon & Co position peaked at $1.02M in Q1 2022.
720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Roberts, Glore & Co's 13F filing for Q1 2025, filed 9 May 2025.